Growth Hormone and Prader-Willi Syndrome

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-0-387-33536-0_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader–Willi syndrome

  2008cited by this paper
• Final adult height in children with Prader–Willi syndrome with and without human growth hormone treatment

  2007cited by this paper
• Five‐years growth hormone (GH) treatment in adults with Prader‐Willi syndrome

  2007cited by this paper
• Two years of growth hormone therapy in young children with Prader–Willi syndrome: Physical and neurodevelopmental benefits

  2007cited by this paper
• Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.

  2006cited by this paper
• Management of Prader-Willi syndrome

  2006cited by this paper
• MR of the pituitary in patients with Prader-Willi syndrome: Size determination and imaging findings

  2005cited by this paper
• Lessons from the national cooperative growth study.

  2004cited by this paper
• High Incidence of Hip Dysplasia but Not Slipped Capital Femoral Epiphysis in Patients With Prader-Willi Syndrome

  2004cited by this paper
• Sudden death in growth hormone-treated children with Prader-Willi syndrome.

  2004cited by this paper
• Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator.

  2004cited by this paper
• Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.

  2004cited by this paper
• Transitional care of GH deficiency: when to stop GH therapy.

  2004cited by this paper
• Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).

  2004cited by this paper
• Unexpected death and critical illness in Prader–Willi syndrome: Report of ten individuals

  2004cited by this paper
• Is growth hormone stimulation testing in children still appropriate?

  2004cited by this paper
• Complications and Outcomes of Open Pediatric Forearm Fractures

  2004cited by this paper
• Growth Hormone Improves Body Composition and Motor Development in Infants with Prader-Willi Syndrome After Six Months

  2004cited by this paper
• Prader–Willi syndrome: Causes of death in an international series of 27 cases

  2004cited by this paper
• Cancer Risk Following Growth Hormone Use in Childhood

  2004cited by this paper
• Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

  2004cited by this paper
• Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome.

  2003cited by this paper
• The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.

  2003cited by this paper
• Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.

  2003cited by this paper
• Prader-Willi Syndrome as a Model for Obesity

  2003cited by this paper
• Model for a peripheral signaling defect in Prader-Willi syndrome.

  2003cited by this paper
• Acquired prion disease: iatrogenic CJD, variant CJD, kuru.

  2003cited by this paper
• Obesity and endocrine disease.

  2003cited by this paper
• Carbohydrate Metabolism Is Not Impaired after 3 Years of Growth Hormone Therapy in Children with Prader-Willi Syndrome

  2003cited by this paper
• Long-term experience with GH replacement therapy: efficacy and safety.

  2003cited by this paper
• Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study.

  2002cited by this paper
• Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.

  2002cited by this paper
• Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.

  2002cited by this paper
• Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

  2002cited by this paper
• Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.

  2002cited by this paper
• Disease management of Prader–Willi syndrome

  2002cited by this paper
• Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity.

  2002cited by this paper
• The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.

  2002cited by this paper
• Growth hormone therapy.

  2002cited by this paper
• Sudden Death of an Infant with Prader-Willi Syndrome – Not a Unique Case?

  2002cited by this paper
• Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment

  2002cited by this paper
• Growth without growth hormone.

  2002cited by this paper
• Sudden death of a girl with Prader-Willi syndrome.

  2002cited by this paper
• Optimizing gh therapy in adults and children.

  2001cited by this paper
• Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

  2001cited by this paper
• Growth hormone therapy in Prader–Willi Syndrome

  2001cited by this paper
• Prader-Willi Syndrome: Effects of Human Growth Hormone Treatment

  2001cited by this paper
• Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent

  2001cited by this paper
• Is There Growth Hormone Deficiency in Prader-Willi Syndrome?

  2000cited by this paper
• Leptin concentrations in Prader‐Willi syndrome before and after growth hormone replacement

  2000cited by this paper
• Effects of growth hormone on body composition and bone metabolism

  2000cited by this paper
• Effects of growth hormone treatmentin children with Prader-Willi syndrome

  2000cited by this paper
• GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli

  2000cited by this paper
• Consensus statement - Prader-Willi syndrome: Growth hormone (GH)/insulin-like growth factor axis deficiency and GH treatment

  2000cited by this paper
• Effects of growth hormone on adipose tissue.

  2000cited by this paper
• Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.

  2000cited by this paper
• Spontaneous growth in German children and adolescents with genetically confirmed Prader‐Willi syndrome

  2000cited by this paper
• Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy

  2000cited by this paper
• Body Composition Abnormalities in Children with Prader-Willi Syndrome and Long-Term Effects of Growth Hormone Therapy

  2000cited by this paper
• A Treatment/Control Group Study of Growth Hormone Treatment: Impact on Behavior—A Preliminary Look

  2000cited by this paper
• Prader-Willi Syndrome: The Effect of Growth Hormone on Childhood Body Composition

  2000cited by this paper
• Prader-Willi Syndrome in Adults

  2000cited by this paper
• Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome?

  2000cited by this paper
• Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome

  2000cited by this paper
• Side Effects of Growth Hormone Treatment in Prader-willi Syndrome

  2000cited by this paper
• Growth Hormone Deficiency in Prader-Willi Syndrome

  2000cited by this paper
• Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion.

  2000cited by this paper
• Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.

  2000cited by this paper
• Auxological and Endocrine Evolution of 28 Children with Prader-Willi Syndrome: Effect of GH Therapy in 14 Children

  2000cited by this paper
• Standard growth curves for Japanese patients with Prader-Willi syndrome.

  2000cited by this paper
• Growth hormone treatment increases CO2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome

  1999cited by this paper
• Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.

  1999cited by this paper
• Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.

  1999cited by this paper
• Growth hormone in obesity

  1999cited by this paper
• Growth Hormone Treatment of Children with Prader-Willi Syndrome: Effects on Glucose and Insulin Homeostasis

  1999cited by this paper
• Body composition in Prader‐Willi syndrome: assessment and effects of growth hormone administration

  1999cited by this paper
• Glucose homeostasis in Prader‐Willi syndrome and potential implications of growth hormone therapy

  1999cited by this paper
• Growth Hormone Treatment Downregulates Serum Leptin Levels in Children Independent of Changes in Body Mass Index

  1999cited by this paper
• Clinical endocrinology of human leptin

  1999cited by this paper
• Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test

  1999cited by this paper
• Behavior and personality characteristics of children and young adults with Prader-Willi syndrome: a controlled study.

  1999cited by this paper
• Five years of growth hormone treatment in children with Prader‐Willi syndrome

  1999cited by this paper
• Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome.

  1999cited by this paper
• Physical effects of growth hormone treatment in children with Prader‐Willi syndrome

  1999cited by this paper
• KIGS and KIMS as Tools for Evidence-Based Medicine

  1999cited by this paper
• Growth hormone therapy in adults and children.

  1999cited by this paper
• Growth hormone secretion in Prader-Willi syndrome

  1998cited by this paper
• Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome

  1998cited by this paper
• Effect of growth hormone treatment on insulin action in adipocytes from children with Prader-Willi syndrome.

  1998cited by this paper
• Reduced growth hormone (GH) responsiveness to combined GH‐releasing hormone and pyridostigmine administration in the Prader–Willi syndrome

  1998cited by this paper
• Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults

  1998cited by this paper
• The growth hormone response to hexarelin in patients with Prader-Willi syndrome

  1998cited by this paper
• The Gordon Wilson Lecture. Growth hormone replacement in adults and other uses.

  1998cited by this paper
• Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourably

  1998cited by this paper
• Sudden death in children with Prader-Willy syndrome: a call for collaboration.

  1998cited by this paper
• Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome

  1998cited by this paper
• Photoanthropometric study of craniofacial traits in individuals with Prader‐Willi syndrome on short‐term growth hormone therapy

  1998cited by this paper
• The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

  1998cited by this paper
• Growth Failure in Prader-Willi Syndrome Is Secondary to Growth Hormone Deficiency

  1998cited by this paper
• Prader—Willi syndrome and the hypothalamus

  1997cited by this paper

• Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques.

  2025cites this paper
• Test-retest reliability of the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition for youth with Prader-Willi syndrome.

  2018cites this paper
• Health Supervision for Children With Prader-Willi Syndrome

  2018cites this paper
• Health Supervision for Children With Prader-Willi Syndrome

  2017cites this paper
• IMPRINTED GENES ON CHROMOSOME 15q11-q13 REGION ASPECTS OF PRADER WILLI SYNDROME (PWS) PHENOTYPES AND THEIR THERAPEUTICS MODELS

  2016cites this paper
• Prader-Willi Syndrome

  2016cites this paper
• EFFETTO DELLA VELOCITA' DI ASSUNZIONE DI CIBO E DELLA PALATABILITA' SULLA SECREZIONE DI PEPTIDI GASTROINTESTINALI NELL'OBESITA' SEMPLICE E GENETICA

  2015cites this paper
• Health Supervision for Children with Prader-Willi Syndrome

  2014cites this paper
• Oral and General Findings: Management of Prader-Willi Syndrome

  2013cites this paper
• Inference of gene regulatory interactions from deep sequencing data

  2012cites this paper
• Letter to the Editor: Long-Term Experience with Duodenal Switch in Adolescents

  2012cites this paper
• Health Supervision for Children With Prader-Willi Syndrome

  2011cites this paper
• Role of Alternative Splicing of the 5-HT 2C Receptor in the Prader–Willi Syndrome

  2011cites this paper
• Care of the patient with Prader-Willi syndrome.

  2011cites this paper
• Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome

  2011cites this paper
• The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.

  2010cites this paper
• Guideline for using growth hormone in paediatric patients in South Africa: treatment of growth hormone deficiency and other growth disorders.

  2009cites this paper
• Prader–Willi syndrome

  2009cites this paper
• Body fat excess and stimulated growth hormone levels in adult patients with Prader–Willi syndrome

  2009cites this paper
• Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

  2008cites this paper
• Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome

  2008cites this paper
• Growth Hormone Treatment of Adults with Prader Willi Syndrome and Growth Hormone Deficiency Improves Lean Body Mass , Fractional Body Fat , and Serum Triiodothyronine Without Glucose Impairment : Results From The US Multi-Center Trial

  2008cites this paper
• Prader-Willi Syndrome.

  2008cites this paper
• The Italian National Survey for Prader–Willi syndrome: An epidemiologic study

  2008cites this paper
• Prader-Willi Syndrome: An Update and Review for the Primary Pediatrician

  2007influential citation
• Management of obesity in Prader–Willi syndrome

  2006cites this paper
• Regulation of alternative splicing by snoRNAs.

  2006cites this paper